Doximity, Inc.
| General Information | |
| Business: | We are the leading digital platform for U.S. medical professionals, as measured by the number of U.S. physician members, with over 1.8 million medical professional members as of March 31, 2021. Our members include more than 80% of physicians across all 50 states and every medical specialty.
Our mission is to help every physician be more productive and provide better care for their patients. We are physicians-first, putting technology to work for doctors instead of the other way around. That guiding principle has enabled Doximity to become an essential and trusted professional platform for physicians. Our cloud-based platform provides our members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. Doximity membership is free for physicians. Our revenue-generating customers, primarily pharmaceutical manufacturers and healthcare systems, have access to a suite of commercial solutions that benefit from broad physician usage.
(Note: Doximity priced its IPO on June 24, 2021, at $26 – far above the $20-to-$23 range – on 23.3 million shares, the same number of shares in the prospectus, to raise $605.8 million.)
|
| Industry: | COMPUTER PROGRAMMING SERVICES |
| Employees: | 713 |
| Founded: | 2010 |
| Contact Information | |
| Address | 500 3rd St., Suite 510, San Francisco, CA 94107, and our telephone number is (650) 549-4330500 3rd St., Suite 510, San Francisco, CA 94107, |
| Phone Number | (650) 549-4330 |
| Web Address | http://www.doximity.com/ |
| View Prospectus: | Doximity, Inc. |
| Financial Information | |
| Market Cap | $3831.3mil |
| Revenues | $206.9 mil (last 12 months) |
| Net Income | $50.2 mil (last 12 months) |
| IPO Profile | |
| Symbol | DOCS |
| Exchange | NYSE |
| Shares (millions): | 23.3 |
| Price range | $26.00 - $26.00 |
| Est. $ Volume | $605.8 mil |
| Manager / Joint Managers | Morgan Stanley/ Goldman Sachs/ J.P. Morgan |
| CO-Managers | Piper Sandler/ William Blair/ Canaccord Genuity/ Needham & Co./ Raymond James/ SVB Leerink |
| Expected To Trade: | 6/24/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |